Home » STADA BIDS FOR SERBIAN HEMOFARM -- ACCESS TO 59% CONTRACTUALLY AGREED
STADA BIDS FOR SERBIAN HEMOFARM -- ACCESS TO 59% CONTRACTUALLY AGREED
July 14, 2006
STADA Arzneimittel AG is to completely take over the Serbian Pharmaceuticals Group Hemofarm a.d., Vrsac, Serbia. To this
end, STADA will in Serbia submit a public takeover offer to the Commission for
Securities of the Republic of Serbia for all 3.3 million shares of the company
which has been listed on the stock exchange in Belgrade since 2002. Hemofarm's
management has welcomed STADA's takeover offer.
Pipeline
Review
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
21Oct